CA2274545A1 - Radio frequency transmyocardial revascularization corer - Google Patents
Radio frequency transmyocardial revascularization corer Download PDFInfo
- Publication number
- CA2274545A1 CA2274545A1 CA002274545A CA2274545A CA2274545A1 CA 2274545 A1 CA2274545 A1 CA 2274545A1 CA 002274545 A CA002274545 A CA 002274545A CA 2274545 A CA2274545 A CA 2274545A CA 2274545 A1 CA2274545 A1 CA 2274545A1
- Authority
- CA
- Canada
- Prior art keywords
- catheter
- cutting tip
- radio frequency
- distal end
- lumen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/04—Endoscopic instruments
- A61B2010/045—Needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00392—Transmyocardial revascularisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00601—Cutting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/1206—Generators therefor
- A61B2018/1246—Generators therefor characterised by the output polarity
- A61B2018/1253—Generators therefor characterised by the output polarity monopolar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2218/00—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2218/001—Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
- A61B2218/007—Aspiration
Abstract
This invention is an RF activated catheter apparatus (100) for performing transmyocardial revascularization. The catheter apparatus includes an elongate catheter shaft (118) having proximal and distal ends, the distal end including an RF emitter (148) which is coupled to an RF generator (26) for cutting channels into the myocardium of a patient's heart.
Description
RADIO FREQUENCY TRANSMYOCARDIAL REVASCULARIZATION CORER
Related Cases This application claims the benefit of U.S.
Provisional Application No. 60/032,804, filed December 9, 1996. The present application is related to U.S. Patent Application Serial No. , filed entitled "Radio Frequency Transmyocardial Revascularization", and is incorporated herein by reference.
Field of the Invention The present invention pertains to a device and method for performing transmyocardial revascularization (TMR) using radio frequency (RF) energy.
Backcrround of the Invention A number of techniques are available for treating cardiovascular disease such as cardiovascular bypass surgery, coronary angioplasty, laser angioplasty and atherectomy. These techniques are generally applied to bypass or open lesions in coronary vessels to restore or increase blood flow to the heart muscle. In some patient's the number of lesions is so great, or the location so remote in the patient's vasculature, that restoring adequate blood flow to the heart muscle is difficult.
TMR has been developed as an alternative to these techniques which are directed at bypassing or removing lesions. TMR is performed by boring channels directly into the myocardium of the heart. In one such procedure, a laser catheter is advanced into the left ventricle.
Laser radiation is then focused on the myocardium to create a channel. It has been found that creating several channels may be useful.
TMR has been performed by forming channels with laser energy as described above. TMR has also been performed by cutting a channel with a sharpened probe or blade. The channels cut by laser have a width proportional to the width of the focused laser radiation used to make the channels. When a laser is used, tissue is vaporized to form the channel. When the procedure is performed with a blade, tissue is not removed, but merely pierced or cut.
Lasers used to performed TMR can be costly and the depth of the channels formed can be difficult to control.
Cutting the myocardium with a blade does not remove material from the incision. Removing, or in the case of the TMR laser techniques, vaporization of tissue is believed to enhance the success of the TMR procedure.
Related Cases This application claims the benefit of U.S.
Provisional Application No. 60/032,804, filed December 9, 1996. The present application is related to U.S. Patent Application Serial No. , filed entitled "Radio Frequency Transmyocardial Revascularization", and is incorporated herein by reference.
Field of the Invention The present invention pertains to a device and method for performing transmyocardial revascularization (TMR) using radio frequency (RF) energy.
Backcrround of the Invention A number of techniques are available for treating cardiovascular disease such as cardiovascular bypass surgery, coronary angioplasty, laser angioplasty and atherectomy. These techniques are generally applied to bypass or open lesions in coronary vessels to restore or increase blood flow to the heart muscle. In some patient's the number of lesions is so great, or the location so remote in the patient's vasculature, that restoring adequate blood flow to the heart muscle is difficult.
TMR has been developed as an alternative to these techniques which are directed at bypassing or removing lesions. TMR is performed by boring channels directly into the myocardium of the heart. In one such procedure, a laser catheter is advanced into the left ventricle.
Laser radiation is then focused on the myocardium to create a channel. It has been found that creating several channels may be useful.
TMR has been performed by forming channels with laser energy as described above. TMR has also been performed by cutting a channel with a sharpened probe or blade. The channels cut by laser have a width proportional to the width of the focused laser radiation used to make the channels. When a laser is used, tissue is vaporized to form the channel. When the procedure is performed with a blade, tissue is not removed, but merely pierced or cut.
Lasers used to performed TMR can be costly and the depth of the channels formed can be difficult to control.
Cutting the myocardium with a blade does not remove material from the incision. Removing, or in the case of the TMR laser techniques, vaporization of tissue is believed to enhance the success of the TMR procedure.
Summary of the Invention The present invention pertains to an apparatus and method for performing TMR using RF energy. The apparatus and method of the present invention provides a means for performing TMR by creating channels in the myocardium of the patient's heart which can vary in length and width.
The depth of the channels is generally believed to be directly proportional to the distance which the catheter of the present invention is advanced into the patient's myocardium.
Two theories underlie this procedure. The leading theory holds that creation of the channels causes angiogenesis as a healing response. When angiogenesis occurs, additional blood vessels grow in the myocardium near the channels. The second theory of TMR is that the creation of channels provides direct access of pooled blood in the heart to the heart muscle.
In one embodiment of the present invention, an RF
activated catheter is provided for boring channels into the myocardium of a patient's heart. The RF activated catheter includes an elongate shaft having a proximal end and a distal end. A lumen extends through the shaft between the proximal and distal ends. A cutting tip is disposed at the distal end of the shaft . The cutting tip has proximal and distal ends and a lumen extending therebetween in fluid communication with the shaft lumen.
A wire connects the cutting tip to an RF generator. The distal end of the tip is sharpened.
The catheter is used in a catheter assembly including an RF generator coupled to the cutting tip. A
vacuum source is connected to the catheter proximate its proximal end and is in fluid communication with the catheter shaft lumen.
The catheter assembly preferably includes a second catheter having a proximal end and a distal end and a lumen extending therethrough between the ends. The first catheter can be advanced through the lumen of the second catheter. The second catheter preferably includes a balloon disposed around and at its distal end. An inflation lumen is provided through the second catheter in fluid communication with the balloon.
To perform TMR using this catheter assembly, the cutting tip is advanced to the patient's heart. This is preferably done percutaneously via the femoral artery.
The RF generator is activated to deliver RF energy to the cutting tip. The cutting tip is advanced into the myocardium of the patient's heart to form channels therein. A second catheter can be disposed over the distal cutting tip to isolate the cutting tip from pooled blood within the patient's ventricle. Tissue within the cutting tip can be aspirated through the RF activated catheter.
The depth of the channels is generally believed to be directly proportional to the distance which the catheter of the present invention is advanced into the patient's myocardium.
Two theories underlie this procedure. The leading theory holds that creation of the channels causes angiogenesis as a healing response. When angiogenesis occurs, additional blood vessels grow in the myocardium near the channels. The second theory of TMR is that the creation of channels provides direct access of pooled blood in the heart to the heart muscle.
In one embodiment of the present invention, an RF
activated catheter is provided for boring channels into the myocardium of a patient's heart. The RF activated catheter includes an elongate shaft having a proximal end and a distal end. A lumen extends through the shaft between the proximal and distal ends. A cutting tip is disposed at the distal end of the shaft . The cutting tip has proximal and distal ends and a lumen extending therebetween in fluid communication with the shaft lumen.
A wire connects the cutting tip to an RF generator. The distal end of the tip is sharpened.
The catheter is used in a catheter assembly including an RF generator coupled to the cutting tip. A
vacuum source is connected to the catheter proximate its proximal end and is in fluid communication with the catheter shaft lumen.
The catheter assembly preferably includes a second catheter having a proximal end and a distal end and a lumen extending therethrough between the ends. The first catheter can be advanced through the lumen of the second catheter. The second catheter preferably includes a balloon disposed around and at its distal end. An inflation lumen is provided through the second catheter in fluid communication with the balloon.
To perform TMR using this catheter assembly, the cutting tip is advanced to the patient's heart. This is preferably done percutaneously via the femoral artery.
The RF generator is activated to deliver RF energy to the cutting tip. The cutting tip is advanced into the myocardium of the patient's heart to form channels therein. A second catheter can be disposed over the distal cutting tip to isolate the cutting tip from pooled blood within the patient's ventricle. Tissue within the cutting tip can be aspirated through the RF activated catheter.
Brief Description of the DrawincLs Figure 1 is a cut-away view of a human heart including an RF transmyocardial revascularization catheter apparatus in accordance with the present invention;
Figure 2 is a diagram of the RF transmyocardial revascularization assembly including RF generator ground plane and catheter; and Figure 3 is a cross sectional view of the distal end of the catheter apparatus of Figure 2.
Detailed Description of the Invention Referring now to the drawings wherein like reference numerals represent like elements throughout the several views, Figure 1 is a view of a portion of an radio frequency transmyocardial revascularization (RF TMR) catheter assembly 100 disposed within an aorta 12 and a left ventricle 14 of a heart 16. The elements of catheter assembly shown in Figure 1 include an RF
activated catheter 118, partially extending from a tubular catheter 120. Catheter 118 can be deflectable or steerable with wires (not shown). Catheter 120 can be a guide catheter, deflectable tip catheter or the like, for advancing RF activated catheter 118 therethrough or to shield portions of a patient's anatomy from RF energy emitted from catheter 118. Three channels 22 cut by catheter 118 are shown in myocardium 24 of heart 16. As a consequence of creating these channels by performing the TMR procedure, it is believed that revascularization of the myocardium near the channels occurs by angiogenesis, the channels themselves provide access by pooled blood from ventricle 14 to myocardial tissue or both.
Figure 2 is an embodiment 100 of the RF TMR catheter assembly in accordance with the present invention.
Embodiment 100 includes an RF activated catheter 118 electrically connected at its proximal end near handle 136 to RF generator 26 by cable 34. Disposed at the distal end of catheter 118 is a cutting tip 148. A
vacuum generator 156 is fluidly connected by tube 158 to catheter 118 at a tee 160, which is in turn is in fluid communication with distal tip 148 by way of a lumen (Figure 3) 162 extending through catheter 118. Vacuum generator 156 is connected to a power source by way of cable 164 to remove tissue to avoid embolizing or to take a specimen.
Catheter 118 as shown in Figure 2 is disposed through a tubular catheter 120 having a balloon 166 disposed at its distal end. Disposed at the proximal end of catheter 120 is an adaptor 140 having a side arm 142 in fluid communication with a central lumen 168 (Figure 3) extending through catheter 120. A second side branch 170 of adaptor 140 is in fluid communication with an inflation lumen 172 ( Figure 3 ) extending through catheter 120 to balloon 166.
Figure 3 is a cross sectional view of the distal ends of catheters 118 and 120. In this view, the distal end of catheter 120 abuts a heart wall 174 of heart 16.
Distal cutting tip 148 of RF activated catheter 118 is shown extended into wall 174. Balloon 166 is shown inflated to shield pooled blood from RF energy. Catheter 120 and balloon 166 can be formed from typical guide catheter and angioplasty balloon materials, respectively, as well known to those skilled in the art.
Catheter 118 preferably includes a shaft portion 176 defining a portion of lumen 162 extending proximally from cutting tip 148, tip 148 defines the distal-most portion of lumen 162. Shaft 176 is readily formed from a biocompatible polymer well known to those skilled in the art of catheter construction having sufficient rigidity to allow cutting tip 148 to be pushed into heart wall 174.
Cutting tip 148 preferably has a sharpened distal edge 178 surrounding the distal opening of lumen 162.
Tip 148 can include a sharp point 180 similar to that of hypodermic needle. The cutting tip 148 is preferably formed from stainless steel or other biocompatible metal.
The proximal end of tip 148 is bonded or adhered to the _7_ distal end of shaft 176 in a manner known to those skilled in the art. The length of tip 148 varies according to channel requirement. In an exemplary embodiment, the outside diameter of cutting tip 148 is one millimeter and the inside diameter is 0.9 millimeters, but may vary depending on channel width desired. An RF transmission wire 182 connects cutting' tip 148 to the proximal end of catheter 118 for interconnection with the RF generator 26.
In use, the cutting tip 148 of catheter 118 and the distal end of catheter 120 are advanced to the patient's heart 16, the hybernatory tissue to be cut having previously been identified by means known to those skilled in the art. Typically, hibernating tissue can be identified by injecting contrast medium into coronary vessels to identify regions of the heart into which the contrast medium does not flow due to obstruction of the vessels into which the medium is injected. In this case, the hibernating region will be identified by the lack of flow or abnormally low flow distally of the obstruction in the coronary vessel or vessels. Alternatively, the contrast medium can be injected directly into the heart chambers to identify areas within the chamber or chambers which have generally stagnant, pooled blood. If contrast medium has been injected into the coronary vessels, those regions of the heart into which the contrast medium does not flow, would be candidates for the RF TMR procedure.
If contrast medium is injected directly into the heart chambers, the regions of the heart adjacent to the generally stagnant pooled blood would be candidates for the RF TMR procedure.
Access to the patient's heart will generally be obtained percutaneously through aorta 12 and ventricle 14. Balloon 166 can be inflated to help shield pooled blood within the ventricle from RF energy. As shown in Figure 5, catheter 118 is advanced from a position A into the myocardium of the patient's heart at position B.
RF generator 26 is activated to emit RF energy from cutting tip 148. As cutting tip 148 is advanced into the myocardium, the RF energy loosens the material within lumen 162 from the heart. A plug of tissue 184 can then be aspirated through lumen 162 by vacuum generator 156.
The diameter of cutting tip 148 can be varied to vary the diameter of the channel formed by this procedure. Additionally, the RF output of RF generator can be varied by increasing pulse duration of the application of RF or the power of the RF radiation to speed tissue removal.
Numerous characteristics and advantages of the invention covered by this document have been set forth in the foregoing description. It will be understood, however, that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of parts without exceeding the scope of the invention.
The inventions's scope is, of course, defined in the language in which the appended claims are expressed.
Figure 2 is a diagram of the RF transmyocardial revascularization assembly including RF generator ground plane and catheter; and Figure 3 is a cross sectional view of the distal end of the catheter apparatus of Figure 2.
Detailed Description of the Invention Referring now to the drawings wherein like reference numerals represent like elements throughout the several views, Figure 1 is a view of a portion of an radio frequency transmyocardial revascularization (RF TMR) catheter assembly 100 disposed within an aorta 12 and a left ventricle 14 of a heart 16. The elements of catheter assembly shown in Figure 1 include an RF
activated catheter 118, partially extending from a tubular catheter 120. Catheter 118 can be deflectable or steerable with wires (not shown). Catheter 120 can be a guide catheter, deflectable tip catheter or the like, for advancing RF activated catheter 118 therethrough or to shield portions of a patient's anatomy from RF energy emitted from catheter 118. Three channels 22 cut by catheter 118 are shown in myocardium 24 of heart 16. As a consequence of creating these channels by performing the TMR procedure, it is believed that revascularization of the myocardium near the channels occurs by angiogenesis, the channels themselves provide access by pooled blood from ventricle 14 to myocardial tissue or both.
Figure 2 is an embodiment 100 of the RF TMR catheter assembly in accordance with the present invention.
Embodiment 100 includes an RF activated catheter 118 electrically connected at its proximal end near handle 136 to RF generator 26 by cable 34. Disposed at the distal end of catheter 118 is a cutting tip 148. A
vacuum generator 156 is fluidly connected by tube 158 to catheter 118 at a tee 160, which is in turn is in fluid communication with distal tip 148 by way of a lumen (Figure 3) 162 extending through catheter 118. Vacuum generator 156 is connected to a power source by way of cable 164 to remove tissue to avoid embolizing or to take a specimen.
Catheter 118 as shown in Figure 2 is disposed through a tubular catheter 120 having a balloon 166 disposed at its distal end. Disposed at the proximal end of catheter 120 is an adaptor 140 having a side arm 142 in fluid communication with a central lumen 168 (Figure 3) extending through catheter 120. A second side branch 170 of adaptor 140 is in fluid communication with an inflation lumen 172 ( Figure 3 ) extending through catheter 120 to balloon 166.
Figure 3 is a cross sectional view of the distal ends of catheters 118 and 120. In this view, the distal end of catheter 120 abuts a heart wall 174 of heart 16.
Distal cutting tip 148 of RF activated catheter 118 is shown extended into wall 174. Balloon 166 is shown inflated to shield pooled blood from RF energy. Catheter 120 and balloon 166 can be formed from typical guide catheter and angioplasty balloon materials, respectively, as well known to those skilled in the art.
Catheter 118 preferably includes a shaft portion 176 defining a portion of lumen 162 extending proximally from cutting tip 148, tip 148 defines the distal-most portion of lumen 162. Shaft 176 is readily formed from a biocompatible polymer well known to those skilled in the art of catheter construction having sufficient rigidity to allow cutting tip 148 to be pushed into heart wall 174.
Cutting tip 148 preferably has a sharpened distal edge 178 surrounding the distal opening of lumen 162.
Tip 148 can include a sharp point 180 similar to that of hypodermic needle. The cutting tip 148 is preferably formed from stainless steel or other biocompatible metal.
The proximal end of tip 148 is bonded or adhered to the _7_ distal end of shaft 176 in a manner known to those skilled in the art. The length of tip 148 varies according to channel requirement. In an exemplary embodiment, the outside diameter of cutting tip 148 is one millimeter and the inside diameter is 0.9 millimeters, but may vary depending on channel width desired. An RF transmission wire 182 connects cutting' tip 148 to the proximal end of catheter 118 for interconnection with the RF generator 26.
In use, the cutting tip 148 of catheter 118 and the distal end of catheter 120 are advanced to the patient's heart 16, the hybernatory tissue to be cut having previously been identified by means known to those skilled in the art. Typically, hibernating tissue can be identified by injecting contrast medium into coronary vessels to identify regions of the heart into which the contrast medium does not flow due to obstruction of the vessels into which the medium is injected. In this case, the hibernating region will be identified by the lack of flow or abnormally low flow distally of the obstruction in the coronary vessel or vessels. Alternatively, the contrast medium can be injected directly into the heart chambers to identify areas within the chamber or chambers which have generally stagnant, pooled blood. If contrast medium has been injected into the coronary vessels, those regions of the heart into which the contrast medium does not flow, would be candidates for the RF TMR procedure.
If contrast medium is injected directly into the heart chambers, the regions of the heart adjacent to the generally stagnant pooled blood would be candidates for the RF TMR procedure.
Access to the patient's heart will generally be obtained percutaneously through aorta 12 and ventricle 14. Balloon 166 can be inflated to help shield pooled blood within the ventricle from RF energy. As shown in Figure 5, catheter 118 is advanced from a position A into the myocardium of the patient's heart at position B.
RF generator 26 is activated to emit RF energy from cutting tip 148. As cutting tip 148 is advanced into the myocardium, the RF energy loosens the material within lumen 162 from the heart. A plug of tissue 184 can then be aspirated through lumen 162 by vacuum generator 156.
The diameter of cutting tip 148 can be varied to vary the diameter of the channel formed by this procedure. Additionally, the RF output of RF generator can be varied by increasing pulse duration of the application of RF or the power of the RF radiation to speed tissue removal.
Numerous characteristics and advantages of the invention covered by this document have been set forth in the foregoing description. It will be understood, however, that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of parts without exceeding the scope of the invention.
The inventions's scope is, of course, defined in the language in which the appended claims are expressed.
Claims (14)
1. A radio frequency activated catheter, comprising:
an elongate shaft having a proximal end and a distal end and a lumen therethrough extending between the proximal and distal ends;
a cutting tip disposed at the distal end of the shaft, the cutting tip having a proximal end a distal end and a lumen extending therebetween in fluid communication with the shaft lumen; and means for connecting the cutting tip to a radio frequency generator.
an elongate shaft having a proximal end and a distal end and a lumen therethrough extending between the proximal and distal ends;
a cutting tip disposed at the distal end of the shaft, the cutting tip having a proximal end a distal end and a lumen extending therebetween in fluid communication with the shaft lumen; and means for connecting the cutting tip to a radio frequency generator.
2. A radio frequency activated catheter in accordance with claim 1, wherein the cutting tip is metallic.
3. A radio frequency activated catheter in accordance with claim 2, wherein the distal end of the cutting tip is sharpened.
4. A radio frequency activated catheter in accordance with claim 1, wherein the means for connecting includes wire.
5. A radio frequency activated catheter assembly, comprising:
a first catheter including an elongate shaft having a proximal end and distal end, a lumen extending therethrough between the proximal and distal ends, and a cutting tip disposed at the distal end of the shaft, the cutting tip having a proximal end and a distal end, and a lumen extending therebetween in fluid communication with the shaft lumen;
a radio frequency generator;
a means for connecting the cutting tip to the radio frequency generator; and a vacuum source connected to the catheter proximate the proximal end of the catheter and in fluid communication with the lumens.
a first catheter including an elongate shaft having a proximal end and distal end, a lumen extending therethrough between the proximal and distal ends, and a cutting tip disposed at the distal end of the shaft, the cutting tip having a proximal end and a distal end, and a lumen extending therebetween in fluid communication with the shaft lumen;
a radio frequency generator;
a means for connecting the cutting tip to the radio frequency generator; and a vacuum source connected to the catheter proximate the proximal end of the catheter and in fluid communication with the lumens.
6. A radio frequency activated catheter assembly in accordance with claim 5, further comprising a second catheter having a proximal end and a distal end and a lumen extending therebetween, and the radio frequency catheter being disposed at least partially within the lumen of the second catheter.
7. A radio frequency activated catheter assembly in accordance with claim 5, wherein the second catheter further comprises a balloon disposed at the distal end thereof and an inflation lumen extending between the proximal and distal ends of the second catheter being in fluid communication with the balloon.
8. A radio frequency activated catheter assembly in accordance with claim 5, wherein the cutting tip is metallic.
9. A radio frequency activated catheter assembly in accordance with claim 8, wherein the distal end of the cutting tip is sharpened.
10. A radio frequency activated catheter assembly in accordance with claim 5, wherein the means for connecting includes wire.
11. A method of performing a transmyocardial revascularization, comprising the steps of:
providing a catheter including an elongate shaft having a proximal end and a distal end and a lumen extending therebetween, and a cutting tip disposed at the distal end of the shaft, the cutting tip having a proximal end and a distal end and lumen extending therebetween in fluid communication with the shaft lumen, the cutting tip being coupled to a radio frequency generator;
advancing the cutting tip to a patient's heart;
activating the radio frequency generator to deliver radio frequency energy to the cutting tip; and advancing the cutting tip into the myocardium of the patient's heart to bore a channel therein.
providing a catheter including an elongate shaft having a proximal end and a distal end and a lumen extending therebetween, and a cutting tip disposed at the distal end of the shaft, the cutting tip having a proximal end and a distal end and lumen extending therebetween in fluid communication with the shaft lumen, the cutting tip being coupled to a radio frequency generator;
advancing the cutting tip to a patient's heart;
activating the radio frequency generator to deliver radio frequency energy to the cutting tip; and advancing the cutting tip into the myocardium of the patient's heart to bore a channel therein.
12. A method of performing transmyocardial revascularization in accordance with claim 11, wherein the cutting tip is advanced into the patient' s ventricle.
13. A method of performing transmyocardial revascularization in accordance with claim 12, further comprising the steps of:
providing a second catheter having a proximal end and a distal end and lumen extending therebetween;
disposing the second catheter over the first catheter such that the distal end of the first catheter is proximate the distal end of the second catheter;
bringing the distal end of the second catheter into contact with the patient's heart while the radio frequency catheter extends through the lumen of the second catheter;
inflating a balloon disposed at the distal end of the second catheter to isolate the cutting tip from the blood pool within the patient's ventricle.
providing a second catheter having a proximal end and a distal end and lumen extending therebetween;
disposing the second catheter over the first catheter such that the distal end of the first catheter is proximate the distal end of the second catheter;
bringing the distal end of the second catheter into contact with the patient's heart while the radio frequency catheter extends through the lumen of the second catheter;
inflating a balloon disposed at the distal end of the second catheter to isolate the cutting tip from the blood pool within the patient's ventricle.
14. A method of performing transmyocardial revascularization in accordance with claim 11, further comprising the step of aspirating tissue from within the cutting tip through the lumen of the first catheter.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US032,804 | 1987-04-01 | ||
| US3280496P | 1996-12-09 | 1996-12-09 | |
| US08/792,094 US5944716A (en) | 1996-12-09 | 1997-01-31 | Radio frequency transmyocardial revascularization corer |
| US792,094 | 1997-01-31 | ||
| PCT/US1997/022591 WO1998025533A1 (en) | 1996-12-09 | 1997-12-09 | Radio frequency transmyocardial revascularization corer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2274545A1 true CA2274545A1 (en) | 1998-06-18 |
Family
ID=26708913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002274545A Abandoned CA2274545A1 (en) | 1996-12-09 | 1997-12-09 | Radio frequency transmyocardial revascularization corer |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US5944716A (en) |
| EP (1) | EP0973455A4 (en) |
| CA (1) | CA2274545A1 (en) |
| DE (1) | DE973455T1 (en) |
| WO (1) | WO1998025533A1 (en) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2234389A1 (en) * | 1995-10-13 | 1997-04-17 | Transvascular, Inc. | A device, system and method for interstitial transvascular intervention |
| US6302875B1 (en) | 1996-10-11 | 2001-10-16 | Transvascular, Inc. | Catheters and related devices for forming passageways between blood vessels or other anatomical structures |
| JPH11514269A (en) | 1995-10-13 | 1999-12-07 | トランスバスキュラー インコーポレイテッド | Methods and apparatus for bypassing arterial occlusion and / or performing other transvascular approaches |
| US6090083A (en) | 1996-01-31 | 2000-07-18 | Scimed Life Systems, Inc. | Low profile valve and balloon catheter |
| US6102926A (en) | 1996-12-02 | 2000-08-15 | Angiotrax, Inc. | Apparatus for percutaneously performing myocardial revascularization having means for sensing tissue parameters and methods of use |
| US6051008A (en) * | 1996-12-02 | 2000-04-18 | Angiotrax, Inc. | Apparatus having stabilization members for percutaneously performing surgery and methods of use |
| US6120520A (en) | 1997-05-27 | 2000-09-19 | Angiotrax, Inc. | Apparatus and methods for stimulating revascularization and/or tissue growth |
| US5968059A (en) | 1997-03-06 | 1999-10-19 | Scimed Life Systems, Inc. | Transmyocardial revascularization catheter and method |
| US6106520A (en) * | 1997-09-30 | 2000-08-22 | Hearten Medical, Inc. | Endocardial device for producing reversible damage to heart tissue |
| US6162214A (en) * | 1997-10-30 | 2000-12-19 | Eclipse Surgical Technologies, Inc. | Corning device for myocardial revascularization |
| US6561998B1 (en) | 1998-04-07 | 2003-05-13 | Transvascular, Inc. | Transluminal devices, systems and methods for enlarging interstitial penetration tracts |
| US6296639B1 (en) | 1999-02-12 | 2001-10-02 | Novacept | Apparatuses and methods for interstitial tissue removal |
| US6254564B1 (en) | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
| US6117130A (en) * | 1998-09-24 | 2000-09-12 | Abiomed, Inc. | Coring device for myocardial revascularization |
| US6176856B1 (en) * | 1998-12-18 | 2001-01-23 | Eclipse Surgical Technologies, Inc | Resistive heating system and apparatus for improving blood flow in the heart |
| US6217575B1 (en) | 1999-02-24 | 2001-04-17 | Scimed Life Systems, Inc. | PMR catheter |
| US6468271B1 (en) | 1999-02-24 | 2002-10-22 | Scimed Life Systems, Inc. | Device and method for percutaneous myocardial revascularization |
| US6287297B1 (en) | 1999-03-05 | 2001-09-11 | Plc Medical Systems, Inc. | Energy delivery system and method for performing myocardial revascular |
| US6475185B1 (en) * | 2000-02-24 | 2002-11-05 | Scimed Life Systems, Inc. | Occlusion device |
| AU2001249308A1 (en) * | 2000-03-24 | 2001-10-15 | Johns Hopkins University | Peritoneal cavity device and method |
| AU2001273421A1 (en) | 2000-07-13 | 2002-01-30 | Bioheart, Inc. | Deployment system for myocardial cellular material |
| US6669691B1 (en) * | 2000-07-18 | 2003-12-30 | Scimed Life Systems, Inc. | Epicardial myocardial revascularization and denervation methods and apparatus |
| US6595958B1 (en) * | 2000-08-08 | 2003-07-22 | Scimed Life Systems, Inc. | Tortuous path injection device and method |
| US6893421B1 (en) * | 2000-08-08 | 2005-05-17 | Scimed Life Systems, Inc. | Catheter shaft assembly |
| US6613017B1 (en) | 2000-08-08 | 2003-09-02 | Scimed Life Systems, Inc. | Controlled depth injection device and method |
| US6533779B2 (en) | 2001-01-16 | 2003-03-18 | Scimed Life Systems, Inc. | PMR catheter and associated methods |
| US6740040B1 (en) * | 2001-01-30 | 2004-05-25 | Advanced Cardiovascular Systems, Inc. | Ultrasound energy driven intraventricular catheter to treat ischemia |
| US6544220B2 (en) | 2001-02-14 | 2003-04-08 | Scimed Life Systems, Inc. | Fluid jet PMR |
| US6508783B2 (en) | 2001-03-14 | 2003-01-21 | Scimed Life Systems, Inc. | Ultrasound method for revascularization and drug delivery |
| US6623437B2 (en) * | 2001-08-28 | 2003-09-23 | Rex Medical, L.P. | Tissue biopsy apparatus |
| US6589240B2 (en) | 2001-08-28 | 2003-07-08 | Rex Medical, L.P. | Tissue biopsy apparatus with collapsible cutter |
| US7169127B2 (en) * | 2002-02-21 | 2007-01-30 | Boston Scientific Scimed, Inc. | Pressure apron direct injection catheter |
| US7108685B2 (en) * | 2002-04-15 | 2006-09-19 | Boston Scientific Scimed, Inc. | Patch stabilization of rods for treatment of cardiac muscle |
| US8308708B2 (en) | 2003-07-15 | 2012-11-13 | Abbott Cardiovascular Systems Inc. | Deployment system for myocardial cellular material |
| US9232948B2 (en) | 2003-12-23 | 2016-01-12 | Stryker Corporation | Catheter with distal occlusion apparatus |
| DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
| US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
| US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
| ES2903231T3 (en) | 2008-02-26 | 2022-03-31 | Jenavalve Tech Inc | Stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
| JP2013526388A (en) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | Artificial heart valve, and transcatheter delivery prosthesis comprising an artificial heart valve and a stent |
| JP6563394B2 (en) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Radially foldable frame for an artificial valve and method for manufacturing the frame |
| US10709555B2 (en) | 2015-05-01 | 2020-07-14 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
| EP3454795B1 (en) | 2016-05-13 | 2023-01-11 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system |
| JP7094965B2 (en) | 2017-01-27 | 2022-07-04 | イエナバルブ テクノロジー インク | Heart valve imitation |
| WO2019209921A1 (en) * | 2018-04-25 | 2019-10-31 | Boston Scientific Scimed, Inc. | Multifunctional electrosurgical instruments with dynamic electrode assemblies |
| US11805998B2 (en) | 2020-04-20 | 2023-11-07 | Covidien Lp | Devices and methods for obtaining adenomyosis and other biopsy samples |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5370675A (en) * | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
| US4790311A (en) * | 1986-06-03 | 1988-12-13 | Ruiz Oscar F | Radio frequency angioplasty catheter system |
| US4896671A (en) * | 1988-08-01 | 1990-01-30 | C. R. Bard, Inc. | Catheter with contoured ablation electrode |
| US5047026A (en) * | 1989-09-29 | 1991-09-10 | Everest Medical Corporation | Electrosurgical implement for tunneling through tissue |
| US5364393A (en) * | 1990-07-02 | 1994-11-15 | Heart Technology, Inc. | Tissue dissipative recanalization catheter |
| US5700259A (en) * | 1990-09-24 | 1997-12-23 | Plc Medical Systems, Inc. | Thoracoscopic transmyocardial revascularization handpiece assembly |
| US5389096A (en) * | 1990-12-18 | 1995-02-14 | Advanced Cardiovascular Systems | System and method for percutaneous myocardial revascularization |
| US5093877A (en) * | 1990-10-30 | 1992-03-03 | Advanced Cardiovascular Systems | Optical fiber lasing apparatus lens |
| US5380316A (en) * | 1990-12-18 | 1995-01-10 | Advanced Cardiovascular Systems, Inc. | Method for intra-operative myocardial device revascularization |
| US5697882A (en) * | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
| US5683366A (en) * | 1992-01-07 | 1997-11-04 | Arthrocare Corporation | System and method for electrosurgical tissue canalization |
| DE69225812T2 (en) * | 1992-01-13 | 1998-10-01 | Schneider Usa Inc | CUTTING DEVICE FOR ATHEREECTOMY CATHETER |
| US5607405A (en) * | 1992-05-19 | 1997-03-04 | Decker; Rand A. | Surgical insertion device and method |
| US5620414A (en) * | 1992-06-30 | 1997-04-15 | Campbell, Jr.; Robert M. | Apparatus and method for effecting surgical incision through use of a fluid jet |
| US5336222A (en) * | 1993-03-29 | 1994-08-09 | Boston Scientific Corporation | Integrated catheter for diverse in situ tissue therapy |
| US5403311A (en) * | 1993-03-29 | 1995-04-04 | Boston Scientific Corporation | Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue |
| US5651785A (en) * | 1993-09-20 | 1997-07-29 | Abela Laser Systems, Inc. | Optical fiber catheter and method |
| US5681308A (en) * | 1994-06-24 | 1997-10-28 | Stuart D. Edwards | Ablation apparatus for cardiac chambers |
| US5593405A (en) * | 1994-07-16 | 1997-01-14 | Osypka; Peter | Fiber optic endoscope |
| US5591159A (en) * | 1994-11-09 | 1997-01-07 | Taheri; Syde A. | Transcavitary myocardial perfusion apparatus |
| WO1996035469A1 (en) * | 1995-05-10 | 1996-11-14 | Cardiogenesis Corporation | System for treating or diagnosing heart tissue |
| US5672174A (en) * | 1995-08-15 | 1997-09-30 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method |
| DE19537084A1 (en) * | 1995-10-05 | 1997-04-10 | Sievers Hans Hinrich Prof Dr M | Catheter for transmyocardial revasculation with guidable multi=ID main catheter |
| US5769843A (en) * | 1996-02-20 | 1998-06-23 | Cormedica | Percutaneous endomyocardial revascularization |
| US5713894A (en) * | 1996-02-27 | 1998-02-03 | Murphy-Chutorian; Douglas | Combined mechanical/optical system for transmyocardial revascularization |
| US5810836A (en) * | 1996-03-04 | 1998-09-22 | Myocardial Stents, Inc. | Device and method for trans myocardial revascularization (TMR) |
| US5725521A (en) * | 1996-03-29 | 1998-03-10 | Eclipse Surgical Technologies, Inc. | Depth stop apparatus and method for laser-assisted transmyocardial revascularization and other surgical applications |
| US5725523A (en) * | 1996-03-29 | 1998-03-10 | Mueller; Richard L. | Lateral-and posterior-aspect method and apparatus for laser-assisted transmyocardial revascularization and other surgical applications |
| IL118352A0 (en) * | 1996-05-21 | 1996-09-12 | Sudai Amnon | Apparatus and methods for revascularization |
| DE29609350U1 (en) * | 1996-05-24 | 1996-08-29 | P Osypka Mbh Ges Fuer Medizint | Device for perforating the heart wall |
-
1997
- 1997-01-31 US US08/792,094 patent/US5944716A/en not_active Expired - Lifetime
- 1997-12-09 EP EP97952339A patent/EP0973455A4/en not_active Withdrawn
- 1997-12-09 CA CA002274545A patent/CA2274545A1/en not_active Abandoned
- 1997-12-09 DE DE0973455T patent/DE973455T1/en active Pending
- 1997-12-09 WO PCT/US1997/022591 patent/WO1998025533A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US5944716A (en) | 1999-08-31 |
| EP0973455A1 (en) | 2000-01-26 |
| EP0973455A4 (en) | 2000-11-22 |
| WO1998025533A1 (en) | 1998-06-18 |
| DE973455T1 (en) | 2000-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5944716A (en) | Radio frequency transmyocardial revascularization corer | |
| US6030380A (en) | Radio frequency transmyocardial revascularization | |
| US6015405A (en) | Device for forming holes in tissue | |
| US10492855B2 (en) | Recanalizing occluded vessels using radiofrequency energy | |
| US5389096A (en) | System and method for percutaneous myocardial revascularization | |
| US6156031A (en) | Transmyocardial revascularization using radiofrequency energy | |
| AU730720C (en) | Transvascular TMR device and method | |
| US5885272A (en) | System and method for percutaneous myocardial revascularization | |
| US6042581A (en) | Transvascular TMR device and method | |
| US6416490B1 (en) | PMR device and method | |
| US6561998B1 (en) | Transluminal devices, systems and methods for enlarging interstitial penetration tracts | |
| US6156029A (en) | Selective treatment of endocardial/myocardial boundary | |
| US5910150A (en) | Apparatus for performing surgery | |
| WO1998024372A1 (en) | Apparatus and methods for percutaneously performing surgery | |
| US20210307823A1 (en) | Method of surgical perforation via the delivery of energy | |
| EP1018961A1 (en) | Transmyocardial revascularization using radiofrequency energy | |
| US20210353354A1 (en) | Method for single pass large bore transseptal crossing | |
| US6149649A (en) | Radio frequency transmyocardial revascularization channel formation | |
| AU5194701A (en) | Transvascular TMR device and method | |
| AU9409698A (en) | Selective treatment of endocardial/myocardial boundary |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |